Market Research Logo

ProMetic Life Sciences Inc. - Product Pipeline Review - 2016

ProMetic Life Sciences Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘ProMetic Life Sciences Inc. - Product Pipeline Review - 2016’, provides an overview of the ProMetic Life Sciences Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by ProMetic Life Sciences Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of ProMetic Life Sciences Inc.
  • The report provides overview of ProMetic Life Sciences Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses ProMetic Life Sciences Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features ProMetic Life Sciences Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate ProMetic Life Sciences Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for ProMetic Life Sciences Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding ProMetic Life Sciences Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


ProMetic Life Sciences Inc. Snapshot
ProMetic Life Sciences Inc. Overview
Key Information
Key Facts
ProMetic Life Sciences Inc. - Research and Development Overview
Key Therapeutic Areas
ProMetic Life Sciences Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
ProMetic Life Sciences Inc. - Pipeline Products Glance
ProMetic Life Sciences Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
ProMetic Life Sciences Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
ProMetic Life Sciences Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
ProMetic Life Sciences Inc. - Drug Profiles
immune globulin (human)
Product Description
Mechanism of Action
R&D Progress
plasminogen (human)
Product Description
Mechanism of Action
R&D Progress
PBI-4050
Product Description
Mechanism of Action
R&D Progress
alpha-1 proteinase inhibitor (human)
Product Description
Mechanism of Action
R&D Progress
C1 esterase inhibitor (human)
Product Description
Mechanism of Action
R&D Progress
PBI-4419
Product Description
Mechanism of Action
R&D Progress
PBI-4425
Product Description
Mechanism of Action
R&D Progress
PBI-4547
Product Description
Mechanism of Action
R&D Progress
plasminogen (recombinant)
Product Description
Mechanism of Action
R&D Progress
ProMetic Life Sciences Inc. - Pipeline Analysis
ProMetic Life Sciences Inc. - Pipeline Products by Target
ProMetic Life Sciences Inc. - Pipeline Products by Route of Administration
ProMetic Life Sciences Inc. - Pipeline Products by Molecule Type
ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action
ProMetic Life Sciences Inc. - Recent Pipeline Updates
ProMetic Life Sciences Inc. - Dormant Projects
ProMetic Life Sciences Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
ProMetic Life Sciences Inc., Key Information
ProMetic Life Sciences Inc., Key Facts
ProMetic Life Sciences Inc. - Pipeline by Indication, 2016
ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2016
ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2016
ProMetic Life Sciences Inc. - Partnered Products in Pipeline, 2016
ProMetic Life Sciences Inc. - Partnered Products/ Combination Treatment Modalities, 2016
ProMetic Life Sciences Inc. - Phase III, 2016
ProMetic Life Sciences Inc. - Phase II, 2016
ProMetic Life Sciences Inc. - Phase I, 2016
ProMetic Life Sciences Inc. - Preclinical, 2016
ProMetic Life Sciences Inc. - Pipeline by Target, 2016
ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2016
ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2016
ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action, 2016
ProMetic Life Sciences Inc. - Recent Pipeline Updates, 2016
ProMetic Life Sciences Inc. - Dormant Developmental Projects,2016
ProMetic Life Sciences Inc., Other Locations
ProMetic Life Sciences Inc., Subsidiaries
List of Figures
ProMetic Life Sciences Inc. - Pipeline by Top 10 Indication, 2016
ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2016
ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2016
ProMetic Life Sciences Inc. - Pipeline by Target, 2016
ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2016
ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2016
ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report